Frank Neumann
Corporate Officer/Principal at KITE PHARMA INC
Frank Neumann active positions
| Companies | Position | Start | End |
|---|---|---|---|
| KITE PHARMA INC | Corporate Officer/Principal | 31/12/2020 | - |
Career history of Frank Neumann
Former positions of Frank Neumann
| Companies | Position | Start | End |
|---|---|---|---|
| VERASTEM, INC. | Chief Tech/Sci/R&D Officer | 05/01/2021 | 19/01/2021 |
| BLUEBIRD BIO, INC. | Corporate Officer/Principal | - | - |
Training of Frank Neumann
| Heinrich-Heine-Universität Düsseldorf | Doctorate Degree |
| University of Bonn | Doctorate Degree |
Statistics
International
| United States | 4 |
| Germany | 3 |
Operational
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| VERASTEM, INC. | Health Technology |
| BLUEBIRD BIO, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Stock Market
- Insiders
- Frank Neumann
- Experience
